Emcure Pharma to Acquire Remaining 20.42% Stake in Zuventus Healthcare for INR 724.9 Cr

The company’s board of directors has approved entering into an agreement with the minority shareholders of Zuventus Healthcare to acquire their holdings. Emcure currently owns a 79.58% stake in the company.

In a significant move to strengthen its position in the domestic pharmaceutical market, Emcure Pharmaceuticals has announced plans to acquire the remaining 20.42% stake in its subsidiary Zuventus Healthcare.

The deal, valued at ₹724.9 crore, will see Emcure fully consolidate Zuventus as a wholly owned subsidiary.

The company’s board of directors has approved entering into an agreement with the minority shareholders of Zuventus Healthcare to acquire their holdings. Emcure currently owns a 79.58% stake in the company.

Confirming the financial details of the deal, the company stated, “An aggregate consideration of ₹724.9 crore (is) payable in cash in one or more tranches on closing, based on valuation.”

The transaction is expected to be completed in the September quarter of the financial year 2025-26.

Founded in 2002, Zuventus Healthcare has built a strong presence in India’s pharmaceutical sector, offering products across multiple therapeutic segments. Emcure initially acquired a majority stake in Zuventus and has since steadily increased its holding.

The latest acquisition aligns with Emcure’s strategy to consolidate and strengthen its domestic business. In its filing, the company noted that the domestic market remains a core focus area, and the transaction would help unlock operational synergies.

“The domestic market remains a strategic priority for Emcure. This transaction will enable full financial consolidation of Zuventus and drive long-term value creation for Emcure, through alignment across its domestic business and unlock synergies,” the company added.

The move is expected to support Emcure’s broader plans of reinforcing its market leadership in India and optimizing its integrated pharmaceutical operations.

Stay tuned for more such updates on Digital Health News